5-Amino-1MQ is a small molecule NNMT inhibitor, not a peptide, although it is sold alongside peptides. The verified evidence is preclinical: selective NNMT inhibitors were developed and characterized in laboratory studies, and NNMT inhibition improved obesity-related metabolic measures in rodents. No published human trials of this compound were verified.

5-Amino-1MQ

5-Amino-1MQ is a small molecule NNMT inhibitor, not a peptide, although it is sold alongside peptides. The verified evidence is preclinical:...

About:

A small-molecule NNMT inhibitor, not a peptide, marketed alongside peptides and studied for metabolic effects in rodents.

MetabolicCapsules or research liquid

What does this peptide do?

Human evidence is limited or indirect. Research focuses on metabolic.

Metabolic research

An NNMT inhibitor studied for metabolic effects in rodents.

Evidence grade

Highest evidence grade among the graded claims: C. Grades reflect study strength, not benefit.

What are the benefits and side effects of this peptide

What research says it may help with

The verified evidence is preclinical: selective NNMT inhibitors were developed and characterized in laboratory studies, and NNMT inhibition improved obesity-related metabolic measures in rodents.
No published human trials of this compound were verified.

Who should avoid it

People who are pregnant or breastfeeding
Children and adolescents
People taking prescription metabolic or weight-loss medication, where no interaction data exists
Known hypersensitivity to the compound

See the safety section. Absence of a flag is not evidence of safety.

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.